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CASE REPORT
Late infectious endocarditis of surgical 
patch closure of atrial septal defects diagnosed 
by 18F-fluorodeoxyglucose gated cardiac 
computed tomography (18F-FDG-PET/CT):  
a case report
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Abstract 
Background: In contrast to percutaneous atrial septal occluder device, surgical patch closure of atrial defects was 
known to be no infective endocarditis risk.
Case presentation: We herein report the first case of late endocarditis of surgical patch closure of atrial septal 
defects occurred at 47-year after surgery. On September 2014, a 56-year-old immunocompetent French Caucasian 
man was admitted into the Emergency Department for 3-week history of headache, acute decrease of psychomo-
tor performance and fever at 40 °C. The diagnosis has been evoked during his admission for the management of a 
brain abscess and confirmed using 18F-fluorodeoxyglucose gated cardiac computed tomography (18F-FDG-PET/CT). 
Bacterial cultures of surgical deep samples of brain abscess were positive for Streptococcus intermedius and Aggregati-
bacter aphrophilus as identified by the matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass 
spectrometry and confirmed with 16S rRNA gene sequencing. The patient was treated by antibiotics for 8 weeks and 
surgical patch closure removal.
Conclusions: In summary, late endocarditis on surgical patch and on percutaneous atrial septal occluder device of 
atrial septal defects is rare. Cardiac imaging by the 18F-fluorodeoxyglucose gated cardiac computed tomography 
(18F-FDG-PET/CT) could improve the diagnosis and care endocarditis on surgical patch closure of atrial septal defects 
while transthoracic and transesophageal echocardiography remained difficult to interpret.
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Background
Infectious complication of atrial septal occlude device is 
rare that represented about 0.1 % of cases [1]. We herein 
report the first case of endocarditis at 47-year after surgi-
cal closure of atrial septal defects discovered by positron 
emission tomography with 18F-fluorodeoxyglucose gated 
cardiac computed tomography (18F-FDG-PET/CT).
Case presentation
On September 2014, a 56-year-old immunocompetent 
French Caucasian man was admitted into the Emer-
gency Department for 3-week history of headache, acute 
decrease of psychomotor performance and fever at 
40 °C. In his medical past-history, he underwent a surgi-
cal patch closure of atrial septal defects for patent fora-
men ovale at 9  years old and dental care at 5  months 
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before his admission. Laboratory investigations revealed 
an elevated leukocyte count at 12.6 × 109/L with an ele-
vated neutrophil count at 8.4 × 109/L, a normal platelet 
count at 180 × 109/L, an elevated C reactive protein rate 
at 97 mg/L and negative blood culture. A brain magnetic 
resonance imaging (MRI) revealed a right occipital cere-
bral abscess (27 × 36 × 43 mm, hyper intense T2) (Fig. 1).
He underwent surgical brain abscess drainage. Bacterial 
cultures of surgical deep samples of brain abscess were 
positive for Streptococcus intermedius and Aggregatibac-
ter aphrophilus as identified by the matrix-assisted laser 
desorption/ionization-time of flight (MALDI-TOF) mass 
spectrometry and confirmed with molecular identifica-
tion (16 s gene sequencing). The patient was treated first 
with an empiric antibiotherapy with cefotaxim 4 g every 
8 h associated with metronidazole 500 mg every 8 h and 
cotrimoxazole 800/160 mg every 8 h. One week later, the 
antibiotic treatment was modified for ceftriaxone 2  g/
day associated with metronidazole 500 mg every 8 h and 
rifampicin 300 mg every 8 h.
A transthoracic echocardiographic examination and a 
body scan revealed no abnormality. A transesophageal 
echocardiography showed a high right left shunt sug-
gestive of atrial septal patch dehiscence without direct 
sign of. An 18F-FDG-PET/CT showed an intense lin-
ear hypermetabolism opposite the interauricular sep-
tum compatible with an endocarditis on the intracardiac 
device (Fig.  2). Transesophageal echocardiography after 
6  weeks of antibiotic treatment showed a filamentous 
image opposite the mitral valve and no vegetation image 
was found. A second 18F-FDG-PET/CT kept showing 
hypermetabolism on the surgical patch closure of atrial 
septal defects. The patient was treated by antibiotics for 
8 weeks.
At the end of antibiotic treatment transthoracic echo-
cardiographic examination showed an exclusive right 
left shunt, confirming dehiscence of the surgical patch 
closure of atrial septal defects. Surgical removal of sur-
gical patch closure of atrial septal defects was necessary 
on April 2015 with replacement by a bovine pericardial 
patch. No antibiotics were given during explantation. 
Explanted atrial surgical patch closure of atrial septal 
defects looked swollen and calcified with negative bacte-
rial cultures. The patient recovered without further com-
plication. His hemiparesis fully disappeared; he only kept 
discrete amnesic and attentional failures. He presents a 
sequelae of attentional and memory deficits at 1 year of 
follow-up.
Discussion
In contrast to percutaneous atrial septal occluder device, 
surgical patch closure of atrial septal defects was known 
to be associated with no infective endocarditis risk [2]. 
To our best knowledge, only one case of endocarditis 
on surgical patch of ventricular septal defect [3] and 17 
cases of bacterial endocarditis on percutaneous atrial 
septal occluder device [4–15] have been reported. In our 
case, the late onset of the infection occurred at 47-year 
after surgery, and it suggests that origin of endocardi-
tis of surgical patch closure of atrial septal defects was a 
hematogenous spread of bacteria during the dental care 
at 5  months before. Diagnosis of endocarditis on atrial 
septal occluder device is generally done by transthoracic 
echocardiographic or transesophageal echocardiography. 
Therefore, in our case the diagnosis has been evoked dur-
ing his admission for the management of a brain abscess, 
and established using 18F-FDG-PET/CT while transtho-
racic and transesophageal echocardiography remained 
difficult to interpret. The benefit of 18F-FDG-PET/CT 
has been demonstrated in the diagnosis of prosthetic 
valve endocarditis cardiac device-related endocarditis for 
detect infection by highlighting inflammatory leukocytes 
express a high density of glucose transporters and are 
highly metabolically active with the high spatial resolu-
tion of cardiac tomography and angiography, and it was 
recently added to the diagnosis of infective endocarditis 
criteria [16, 17].
Conclusion
In summary, late endocarditis on surgical patch and on 
percutaneous atrial septal occluder device of atrial septal 
defects is rare. We believe that the contribution of 18F-FDG-
PET/CT could improve the diagnosis and care of endocar-
ditis on surgical patch closure or percutaneous atrial septal 
Fig. 1 A brain magnetic resonance imaging (MRI) showing a unique 
brain abscess (27 × 36 × 43 mm)
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occluder device of atrial septal defects. A prolonged anti-
biotherapy and surgical management with surgical patch 
removal is a major therapeutic option of endocarditis on 
surgical patch closure of atrial septal defects.
Abbreviations
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